Get started
Author

Chrystelle Colas

Observed names: C Colas, C. Colas, Chrystelle Colas (5472488), Colas Chrystelle, Colas, C., Colas, C. (Chrystelle), Colas, Chrystelle
Observed institutions: Centre National de la Recherche Scientifique, Inserm, University of Liège, Université Paris Cité, Université Paris Sciences et Lettres, Belfast City Hospital, Sorbonne Université, Centre hospitalier universitaire de Québec, La Ligue Contre le Cancer, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Instituto Português de Oncologia Francisco Gentil, Hôpital René Huguenin, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Liège, Centre de Recherche Saint-Antoine, Centre hospitalier de l'Université Laval, Hôpital Tenon, Université Laval, ERN GENTURIS, Université Paris Diderot, Chimie et Biologie de la Cellule, Cancer, Hétérogénéité, Instabilité et Plasticité, Université Pierre-et-Marie-Curie, Université Paris Dauphine-PSL, Université de Rouen Normandie, Institut Curie
ORCID: 0000-0001-9146-9346
Observed ORCID: 0000-0001-9146-9346
OpenAlex ID: A5036904943
Peutz–Jeghers syndrome: a systematic review and recommendations for management
2010 · A D Beggs, A R Latchford, et al. · Gut · 824
PDF
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
2013 · Hans F A Vasen, Ignacio Blanco, et al. · Gut · 745
PDF
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
2008 · H F A Vasen, G Möslein, et al. · Gut · 704
PDF
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD)
2014 · Katharina Wimmer, Christian P Kratz, et al. · Journal of Medical Genetics · 485
PDF
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
2022 · Shuai Li, Valentina Silvestri, et al. · Journal of Clinical Oncology · 287
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.
2021 · Li, Shuai, Silvestri, Valentina, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 207
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D)
2014 · H F A Vasen, Z Ghorbanoghli, et al. · Journal of Medical Genetics · 206
PDF
Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome
2013 · Marry H. Nieuwenhuis, C. Marleen Kets, et al. · Familial Cancer · 158
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study
2013 · Patrick R Benusiglio, David Malka, et al. · Journal of Medical Genetics · 151
Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
2020 · Marc Tischkowitz, Chrystelle Colas, et al. · European Journal of Human Genetics · 148
PDF
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
2020 · Daniel R. Barnes, Matti A. Rookus, et al. · Genetics in Medicine · 138
PDF
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
2015 · N Lavoine, C Colas, et al. · Journal of Medical Genetics · 134
Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group
2021 · Melyssa Aronson, Chrystelle Colas, et al. · Journal of Medical Genetics · 131
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors
2017 · Laetitia Marisa, Magali Svrcek, et al. · JNCI Journal of the National Cancer Institute · 127
PDF
Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors
2012 · Isabelle Sourrouille, Florence Coulet, et al. · Familial Cancer · 121
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
2009 · H. F. A. Vasen, G. Möslein, et al. · Familial Cancer · 120
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
2021 · Aung Ko Win, James G. Dowty, et al. · The Lancet Oncology · 116
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
2022 · Li, Shuai, Silvestri, Valentina, et al. · DR-NTU (Nanyang Technological University) · 104
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents
2015 · Sahra Bodo, Chrystelle Colas, et al. · Gastroenterology · 98
PDF
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
2016 · Kate Lawrenson, Siddhartha Kar, et al. · Nature Communications · 90
PDF
Germline MBD4 Mutations and Predisposition to Uveal Melanoma
2020 · Anne-Céline Derrien, Manuel Rodrigues, et al. · JNCI Journal of the National Cancer Institute · 77
PDF
Leiden open variation database of the MUTYH gene
2010 · Astrid A. Out, Carli M.J. Tops, et al. · Human Mutation · 77
PDF
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
2018 · Elodie Girard, Séverine Eon‐Marchais, et al. · International Journal of Cancer · 76
PDF
Disease expression in juvenile polyposis syndrome: a retrospective survey on a cohort of 221 European patients and comparison with a literature-derived cohort of 473 SMAD4/BMPR1A pathogenic variant carriers
2020 · Robert Blatter, Benjamin Tschupp, et al. · Genetics in Medicine · 73
PDF
Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe
2021 · David Humberto Marmolejo, Mark Yu Zheng Wong, et al. · European Journal of Medical Genetics · 66
Works count: 260
Citation count: 8,718
H-index: 45
I10-index: 107
Year
Topic
Type